• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢功能障碍相关酒精性肝病危险因素识别的进展

Advances in identifying risk factors of metabolic dysfunction-associated alcohol-related liver disease.

作者信息

Ye Rui-Qi, Chen Yi-Fan, Ma Chang, Cheng Xi, Guo Wei, Li Sha

机构信息

Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province 430022, China; Xinhua Clinical Medical College, Shanghai Jiao Tong University, Shanghai 200135, China.

College of Basic Medical Sciences, Shanghai Jiao Tong University, Shanghai 200025, China.

出版信息

Biomed Pharmacother. 2025 Jul;188:118191. doi: 10.1016/j.biopha.2025.118191. Epub 2025 May 22.

DOI:10.1016/j.biopha.2025.118191
PMID:40408808
Abstract

Metabolic dysfunction-associated alcohol-related liver disease (MetALD) is an emerging clinical entity that reflects the coexistence of metabolic dysfunction and alcohol-related liver injury. Unlike classical alcoholic liver disease (ALD), MetALD patients often present with lower to moderate alcohol consumption alongside metabolic risk factors such as obesity, insulin resistance, and dyslipidemia. These factors can synergistically worsen liver injury even at lower alcohol intake levels. Alcohol abuse remains a major global health concern, with the liver being the primary target of alcohol's toxic effects. Long-term alcohol exposure, especially when compounded by metabolic dysfunction, can accelerate the progression from steatosis to inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma. Besides alcohol itself, various factors, including genetic predispositions, gender, type of alcoholic beverage, drinking patterns, and co-morbidities such as viral infections (HBV, HCV) modulate disease susceptibility and severity. This review summarizes current knowledge of risk factors contributing to MetALD, highlights the synergistic interactions between metabolic dysfunction and alcohol consumption, and discusses potential strategies for disease prevention and management.

摘要

代谢功能障碍相关酒精性肝病(MetALD)是一种新出现的临床病症,反映了代谢功能障碍与酒精性肝损伤的并存。与经典酒精性肝病(ALD)不同,MetALD患者通常饮酒量较低至中等,同时伴有肥胖、胰岛素抵抗和血脂异常等代谢风险因素。即使在较低的酒精摄入量水平下,这些因素也可协同加重肝损伤。酒精滥用仍然是全球主要的健康问题,肝脏是酒精毒性作用的主要靶器官。长期接触酒精,尤其是在合并代谢功能障碍时,可加速从脂肪变性进展为炎症、纤维化、肝硬化和肝细胞癌。除酒精本身外,包括遗传易感性、性别、酒精饮料类型、饮酒模式以及病毒感染(HBV、HCV)等合并症在内的各种因素,均可调节疾病易感性和严重程度。本综述总结了目前对导致MetALD的危险因素的认识,强调了代谢功能障碍与酒精消费之间的协同相互作用,并讨论了疾病预防和管理的潜在策略。

相似文献

1
Advances in identifying risk factors of metabolic dysfunction-associated alcohol-related liver disease.代谢功能障碍相关酒精性肝病危险因素识别的进展
Biomed Pharmacother. 2025 Jul;188:118191. doi: 10.1016/j.biopha.2025.118191. Epub 2025 May 22.
2
Metabolic Dysfunction and Alcohol-Associated Liver Disease: A Narrative Review.代谢功能障碍与酒精性肝病:一篇叙述性综述
Clin Transl Gastroenterol. 2025 May 1;16(5):e00828. doi: 10.14309/ctg.0000000000000828.
3
MetALD: New Perspectives on an Old Overlooked Disease.线粒体酒精性肝病:一种被长期忽视的古老疾病的新视角
Liver Int. 2025 May;45(5):e70017. doi: 10.1111/liv.70017.
4
Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies.酒精使用与肝病代谢风险因素的相互作用:流行病学研究的批判性回顾。
Alcohol Clin Exp Res. 2020 Feb;44(2):384-403. doi: 10.1111/acer.14271. Epub 2020 Jan 9.
5
Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study.代谢功能障碍相关脂肪性肝病和/或酒精所致肝癌风险:一项全国性研究
Am J Gastroenterol. 2025 Feb 1;120(2):410-419. doi: 10.14309/ajg.0000000000002920. Epub 2024 Jun 27.
6
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease.低至中度饮酒与代谢功能障碍相关脂肪性肝病患者的纤维化增加有关。
J Hepatol. 2024 Dec;81(6):930-940. doi: 10.1016/j.jhep.2024.06.036. Epub 2024 Jul 4.
7
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease.代谢功能障碍与酒精性肝病(MetALD):酒精性肝病专家小组立场声明
J Hepatol. 2025 Apr;82(4):744-756. doi: 10.1016/j.jhep.2024.11.028. Epub 2024 Nov 27.
8
Liver and atherosclerotic risk of alcohol consumption in patients with metabolic dysfunction-associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病患者饮酒与肝脏及动脉粥样硬化风险
Atherosclerosis. 2025 Apr;403:119161. doi: 10.1016/j.atherosclerosis.2025.119161. Epub 2025 Mar 7.
9
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions.饮酒与肥胖:酒精性肝病/非酒精性脂肪性肝病的相互作用。
Semin Liver Dis. 2020 May;40(2):154-162. doi: 10.1055/s-0040-1701443. Epub 2020 Feb 18.
10
Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis.酒精摄入对肝脂肪变性进展的协同和有害影响。
Int J Mol Sci. 2022 Feb 27;23(5):2636. doi: 10.3390/ijms23052636.

引用本文的文献

1
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights.代谢相关脂肪性肝病时代的酒精消费与肝脏代谢:整合营养与病理生理学见解
Nutrients. 2025 Jul 5;17(13):2229. doi: 10.3390/nu17132229.